Surgery to remove of all or part of the kidney (nephrectomy) is recommended. This may include removing the bladder, surrounding tissues, or lymph nodes. A cure is unlikely unless all of the cancer is removed with surgery.
Hormone treatments may make the tumor smaller in some cases.
Chemotherapy is generally not effective for treating kidney cancer. The medicine interleukin-2 (IL-2) may help some patients. Other medicines may be used to treat kidney cancer. Your doctor can tell you more.
Radiation therapy usually does not work for kidney cancer.
You can ease the stress of illness by joining a support group whose members share common experiences and problems.
Sometimes both kidneys are involved. The cancer spreads easily, most often to the lungs and other organs. In about one-third of patients, the cancer has already spread (metastasized) at the time of diagnosis.
How well a patient does depends on how much the cancer has spread and how well treatment works. The survival rate is highest if the tumor is in the early stages and has not spread outside the kidney. If it has spread to the lymph nodes or to other organs, the survival rate is much lower.
Call your health care provider any time you see blood in the urine. Also call if you have any other symptoms of this disorder.
Stop smoking. Follow your health care provider's recommendations in the treatment of kidney disorders, especially those that may require dialysis.
National Cancer Institute: PDQ Renal Cell Cancer Treatment. Bethesda, MD: National Cancer Institute. Date last modified 02/08/2013. Available at http://cancer.gov/cancertopics/pdq/treatment/renalcell/HealthProfessional. Accessed March 7, 2013.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney cancer. Version 1.2013. Available at http://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf. Accessed March 7, 2013.
Pili R,Rodriguez R. Cancer of the kidney. In: Abeloff MD, Armitage JO, Niederhuber JE, et al., eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, PA: Elsevier Churchill-Livingstone; 2008:chap 86.
Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Blackman, Stephanie Slon, and Nissi Wang.